Philips recently announced the launch of Technology Maximizer, a cross-modality program designed to boost the clinical capabilities and performance of imaging equipment through proactive upgrades. Technology Maximizer provides confidence to radiology and cardiology department leaders and clinicians that their systems are up to date and compliant at a fraction of the cost of individual upgrades, according to Philips.

The Society for Vascular Ultrasound (SVU), the Society for Vascular Surgery (SVS) and Medstreaming-M2S announced the development of the Vascular Quality Initiative (VQI) Vascular Ultrasound Registry. This Registry represents an expansion of the SVS VQI, which will combine noninvasive (vascular ultrasound) testing data with vascular treatment and outcomes data, making it possible to analyze the relationships between diagnosis and care provided to patients with vascular disease.

Secant Group, in partnership with its sister company SanaVita Medical, announced new technology to advance cardiovascular regenerative medicine with the development of a synthetic, small-bore vessel that encourages endogenous regeneration and new vessel formation. The technology is based on the company’s textile forming capabilities that can produce a hollow lumen construct infused with Secant’s proprietary Regenerez bioresorbable polymer technology. The new small-bore vessel supports the regeneration of new vascular tissue structures without the need for cell seeding or biologic growth promoters.

January 16, 2018 — Researchers from the NUST MISIS Engineering Center for Industrial Technologies in Russia have developed an innovative technology for the production of magnetic materials and permanent magnets at a reduced cost. This engineering solution will allow scientists to produce affordable and efficient domestic magnetic resonance imaging (MRI) devices for wide use in public health clinics.

Miracor Medical Systems GmbH (Miracor Austria) and Miracor Medical SA (Miracor Medical) announced the closing of €25m as part of a Series D financing round. The new capital will be used to further develop and commercialize the PiCSO Impulse System. The round was led by Ming Capital (Shenzhen, China) and co-led by a strategic investor.

American College of Cardiology (ACC) Chief Executive Officer Shalom “Shal” Jacobovitz will be leaving the College effective Feb. 2, 2018, to lead CiVi Biopharma Inc., a privately held biopharmaceutical company. Cathy Gates, ACC chief operating officer and executive vice president, will serve as interim CEO.

Medtronic plc announced the company’s Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide Aspiration System, adding a tool to its acute ischemic stroke (AIS) product portfolio.

Boston Scientific's Apama multi-electrode ablation balloon to treat atrial fibrillation.
The Boston Scientific Rhythmia HDx high-density electromapping system.
The Biosense Webster multi-electrode ablation balloon.
The Cardiofocus Heartlight laser ablation balloon system.

The development of atrial fibrillation (AFib or AF) ablation technologies over the past 20 years has been a constant exercise to build a better mouse trap. The goal has been to improve patient outcomes, reducing the need for repeat procedures and to reduce procedure times.

Society of Interventional Radiology (SIR)

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now